Emergent Biosolutions Inc’s recently made public that its Director Zoon Kathryn C unloaded Company’s shares for reported $62853.0 on Aug 15 ’25. In the deal valued at $8.87 per share,7,086 shares were sold. As a result of this transaction, Zoon Kathryn C now holds 71,799 shares worth roughly $0.57 million.
Then, KATHRYN ZOON bought 7,086 shares, generating $62,853 in total proceeds.
Before that, DeGolyer Donald W sold 7,844 shares. Emergent Biosolutions Inc shares valued at $67,831 were divested by the Director at a price of $8.65 per share. As a result of the transaction, DeGolyer Donald W now holds 137,659 shares, worth roughly $1.1 million.
H.C. Wainwright initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on December 30, 2024; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. The Benchmark Company also remained covering EBS and has increased its forecast on March 07, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of EBS
On Monday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock fall -1.72% to $8.0. Over the last five days, the stock has gained 5.82%. Emergent Biosolutions Inc shares have risen nearly 5.68% since the year began. Nevertheless, the stocks have fallen -16.32% over the past one year.
How much short interest is there in Emergent Biosolutions Inc?
A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2025-08-29, dropping by -1.24 million shares to a total of 8.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 9.95 million shares. There was a decline of -14.21%, which implies that there is a negative sentiment for the stock.
